カテゴリ： 世界, 医療/バイオ, QYResearch

細胞ベースマルチプレックスアッセイの世界市場2023年：フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他

■ 英語タイトル：Global Cell-Based Multiplex Assays Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7440）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7440
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[細胞ベースマルチプレックスアッセイの世界市場2023年：フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は細胞ベースマルチプレックスアッセイのグローバル市場について調査・分析し、世界の細胞ベースマルチプレックスアッセイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他）、用途別セグメント分析（製薬＆バイオテクノロジー企業、病院＆研究所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、R&D Systems、Bio-Rad Laboratories、Protavio、Illumina、BD、Luminex Corporation、Agilent Technologies、Bio-Techne Corporation、Shimadzu Biotech、Abcam、Merck、Meso Scale Diagnostics、Promega Corporation、Siemens Healthineers、Boster Biological Technologyなどが含まれています。細胞ベースマルチプレックスアッセイのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、細胞ベースマルチプレックスアッセイ市場規模を算出する際に考慮しました。

・細胞ベースマルチプレックスアッセイ市場の概要
- 細胞ベースマルチプレックスアッセイの種類別セグメント
- 世界の細胞ベースマルチプレックスアッセイ市場規模：タイプ別分析（フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他）
- 細胞ベースマルチプレックスアッセイの用途別セグメント
- 世界の細胞ベースマルチプレックスアッセイ市場規模：用途別分析（製薬＆バイオテクノロジー企業、病院＆研究所、その他）
- 世界の細胞ベースマルチプレックスアッセイ市場規模予測（2018年-2029年）

・細胞ベースマルチプレックスアッセイ市場の成長トレンド
- 細胞ベースマルチプレックスアッセイの地域別市場規模（2018年-2029年）
- 細胞ベースマルチプレックスアッセイ市場ダイナミクス
- 細胞ベースマルチプレックスアッセイの業界動向
- 細胞ベースマルチプレックスアッセイ市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他
- 世界の細胞ベースマルチプレックスアッセイのタイプ別市場規模（2018年-2023年）
- 世界の細胞ベースマルチプレックスアッセイのタイプ別市場規模（2024年-2029年）

・用途別セグメント：製薬＆バイオテクノロジー企業、病院＆研究所、その他
- 世界の細胞ベースマルチプレックスアッセイの用途別市場規模（2018年-2023年）
- 世界の細胞ベースマルチプレックスアッセイの用途別市場規模（2024年-2029年）

・細胞ベースマルチプレックスアッセイの地域別市場規模
- 北米の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- 米国の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- ヨーロッパの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- アジア太平洋の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- 中国の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- 日本の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- 韓国の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- インドの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- オーストラリアの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- 中南米の細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）
- 中東・アフリカの細胞ベースマルチプレックスアッセイ市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Thermo Fisher Scientific、R&D Systems、Bio-Rad Laboratories、Protavio、Illumina、BD、Luminex Corporation、Agilent Technologies、Bio-Techne Corporation、Shimadzu Biotech、Abcam、Merck、Meso Scale Diagnostics、Promega Corporation、Siemens Healthineers、Boster Biological Technology

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Cell-Based Multiplex Assays market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cell-Based Multiplex Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cell-Based Multiplex Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cell-Based Multiplex Assays include Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, Protavio, Illumina, BD, Luminex Corporation, Agilent Technologies and Bio-Techne Corporation, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell-Based Multiplex Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Multiplex Assays.
The Cell-Based Multiplex Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell-Based Multiplex Assays market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Based Multiplex Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
R&D Systems
Bio-Rad Laboratories
Protavio
Illumina
BD
Luminex Corporation
Agilent Technologies
Bio-Techne Corporation
Shimadzu Biotech
Abcam
Merck
Meso Scale Diagnostics
Promega Corporation
Siemens Healthineers
Boster Biological Technology
Segment by Type
Flow Cytometry
Fluorescence Detection
Multiplex Real-Time PCR
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Based Multiplex Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Based Multiplex Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry
1.2.3 Fluorescence Detection
1.2.4 Multiplex Real-Time PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cell-Based Multiplex Assays Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Based Multiplex Assays Market Perspective (2018-2029)
2.2 Cell-Based Multiplex Assays Growth Trends by Region
2.2.1 Global Cell-Based Multiplex Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell-Based Multiplex Assays Historic Market Size by Region (2018-2023)
2.2.3 Cell-Based Multiplex Assays Forecasted Market Size by Region (2024-2029)
2.3 Cell-Based Multiplex Assays Market Dynamics
2.3.1 Cell-Based Multiplex Assays Industry Trends
2.3.2 Cell-Based Multiplex Assays Market Drivers
2.3.3 Cell-Based Multiplex Assays Market Challenges
2.3.4 Cell-Based Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Based Multiplex Assays Players by Revenue
3.1.1 Global Top Cell-Based Multiplex Assays Players by Revenue (2018-2023)
3.1.2 Global Cell-Based Multiplex Assays Revenue Market Share by Players (2018-2023)
3.2 Global Cell-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Based Multiplex Assays Revenue
3.4 Global Cell-Based Multiplex Assays Market Concentration Ratio
3.4.1 Global Cell-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Multiplex Assays Revenue in 2022
3.5 Cell-Based Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Cell-Based Multiplex Assays Product Solution and Service
3.7 Date of Enter into Cell-Based Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Multiplex Assays Breakdown Data by Type
4.1 Global Cell-Based Multiplex Assays Historic Market Size by Type (2018-2023)
4.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2024-2029)
5 Cell-Based Multiplex Assays Breakdown Data by Application
5.1 Global Cell-Based Multiplex Assays Historic Market Size by Application (2018-2023)
5.2 Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell-Based Multiplex Assays Market Size (2018-2029)
6.2 North America Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell-Based Multiplex Assays Market Size by Country (2018-2023)
6.4 North America Cell-Based Multiplex Assays Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Based Multiplex Assays Market Size (2018-2029)
7.2 Europe Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell-Based Multiplex Assays Market Size by Country (2018-2023)
7.4 Europe Cell-Based Multiplex Assays Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Based Multiplex Assays Market Size (2018-2029)
8.2 Asia-Pacific Cell-Based Multiplex Assays Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Based Multiplex Assays Market Size (2018-2029)
9.2 Latin America Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell-Based Multiplex Assays Market Size by Country (2018-2023)
9.4 Latin America Cell-Based Multiplex Assays Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Based Multiplex Assays Market Size (2018-2029)
10.2 Middle East & Africa Cell-Based Multiplex Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell-Based Multiplex Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Detail
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Cell-Based Multiplex Assays Introduction
11.2.4 R&D Systems Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.2.5 R&D Systems Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Cell-Based Multiplex Assays Introduction
11.3.4 Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Protavio
11.4.1 Protavio Company Detail
11.4.2 Protavio Business Overview
11.4.3 Protavio Cell-Based Multiplex Assays Introduction
11.4.4 Protavio Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.4.5 Protavio Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Cell-Based Multiplex Assays Introduction
11.5.4 Illumina Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Cell-Based Multiplex Assays Introduction
11.6.4 BD Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.6.5 BD Recent Development
11.7 Luminex Corporation
11.7.1 Luminex Corporation Company Detail
11.7.2 Luminex Corporation Business Overview
11.7.3 Luminex Corporation Cell-Based Multiplex Assays Introduction
11.7.4 Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.7.5 Luminex Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cell-Based Multiplex Assays Introduction
11.8.4 Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Bio-Techne Corporation
11.9.1 Bio-Techne Corporation Company Detail
11.9.2 Bio-Techne Corporation Business Overview
11.9.3 Bio-Techne Corporation Cell-Based Multiplex Assays Introduction
11.9.4 Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.9.5 Bio-Techne Corporation Recent Development
11.10 Shimadzu Biotech
11.10.1 Shimadzu Biotech Company Detail
11.10.2 Shimadzu Biotech Business Overview
11.10.3 Shimadzu Biotech Cell-Based Multiplex Assays Introduction
11.10.4 Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.10.5 Shimadzu Biotech Recent Development
11.11 Abcam
11.11.1 Abcam Company Detail
11.11.2 Abcam Business Overview
11.11.3 Abcam Cell-Based Multiplex Assays Introduction
11.11.4 Abcam Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.11.5 Abcam Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Cell-Based Multiplex Assays Introduction
11.12.4 Merck Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.12.5 Merck Recent Development
11.13 Meso Scale Diagnostics
11.13.1 Meso Scale Diagnostics Company Detail
11.13.2 Meso Scale Diagnostics Business Overview
11.13.3 Meso Scale Diagnostics Cell-Based Multiplex Assays Introduction
11.13.4 Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.13.5 Meso Scale Diagnostics Recent Development
11.14 Promega Corporation
11.14.1 Promega Corporation Company Detail
11.14.2 Promega Corporation Business Overview
11.14.3 Promega Corporation Cell-Based Multiplex Assays Introduction
11.14.4 Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.14.5 Promega Corporation Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Detail
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Cell-Based Multiplex Assays Introduction
11.15.4 Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.15.5 Siemens Healthineers Recent Development
11.16 Boster Biological Technology
11.16.1 Boster Biological Technology Company Detail
11.16.2 Boster Biological Technology Business Overview
11.16.3 Boster Biological Technology Cell-Based Multiplex Assays Introduction
11.16.4 Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2018-2023)
11.16.5 Boster Biological Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cell-Based Multiplex Assays Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Fluorescence Detection
Table 4. Key Players of Multiplex Real-Time PCR
Table 5. Key Players of Others
Table 6. Global Cell-Based Multiplex Assays Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cell-Based Multiplex Assays Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cell-Based Multiplex Assays Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cell-Based Multiplex Assays Market Share by Region (2018-2023)
Table 10. Global Cell-Based Multiplex Assays Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Cell-Based Multiplex Assays Market Share by Region (2024-2029)
Table 12. Cell-Based Multiplex Assays Market Trends
Table 13. Cell-Based Multiplex Assays Market Drivers
Table 14. Cell-Based Multiplex Assays Market Challenges
Table 15. Cell-Based Multiplex Assays Market Restraints
Table 16. Global Cell-Based Multiplex Assays Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cell-Based Multiplex Assays Market Share by Players (2018-2023)
Table 18. Global Top Cell-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Multiplex Assays as of 2022)
Table 19. Ranking of Global Top Cell-Based Multiplex Assays Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cell-Based Multiplex Assays Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cell-Based Multiplex Assays Product Solution and Service
Table 23. Date of Enter into Cell-Based Multiplex Assays Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cell-Based Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cell-Based Multiplex Assays Revenue Market Share by Type (2018-2023)
Table 27. Global Cell-Based Multiplex Assays Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Cell-Based Multiplex Assays Revenue Market Share by Type (2024-2029)
Table 29. Global Cell-Based Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cell-Based Multiplex Assays Revenue Market Share by Application (2018-2023)
Table 31. Global Cell-Based Multiplex Assays Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Cell-Based Multiplex Assays Revenue Market Share by Application (2024-2029)
Table 33. North America Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cell-Based Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cell-Based Multiplex Assays Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Cell-Based Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cell-Based Multiplex Assays Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Cell-Based Multiplex Assays Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cell-Based Multiplex Assays Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Cell-Based Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cell-Based Multiplex Assays Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cell-Based Multiplex Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cell-Based Multiplex Assays Market Size by Country (2024-2029) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Detail
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific Cell-Based Multiplex Assays Product
Table 51. Thermo Fisher Scientific Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. R&D Systems Company Detail
Table 54. R&D Systems Business Overview
Table 55. R&D Systems Cell-Based Multiplex Assays Product
Table 56. R&D Systems Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 57. R&D Systems Recent Development
Table 58. Bio-Rad Laboratories Company Detail
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Cell-Based Multiplex Assays Product
Table 61. Bio-Rad Laboratories Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 62. Bio-Rad Laboratories Recent Development
Table 63. Protavio Company Detail
Table 64. Protavio Business Overview
Table 65. Protavio Cell-Based Multiplex Assays Product
Table 66. Protavio Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 67. Protavio Recent Development
Table 68. Illumina Company Detail
Table 69. Illumina Business Overview
Table 70. Illumina Cell-Based Multiplex Assays Product
Table 71. Illumina Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. BD Company Detail
Table 74. BD Business Overview
Table 75. BD Cell-Based Multiplex Assays Product
Table 76. BD Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 77. BD Recent Development
Table 78. Luminex Corporation Company Detail
Table 79. Luminex Corporation Business Overview
Table 80. Luminex Corporation Cell-Based Multiplex Assays Product
Table 81. Luminex Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 82. Luminex Corporation Recent Development
Table 83. Agilent Technologies Company Detail
Table 84. Agilent Technologies Business Overview
Table 85. Agilent Technologies Cell-Based Multiplex Assays Product
Table 86. Agilent Technologies Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 87. Agilent Technologies Recent Development
Table 88. Bio-Techne Corporation Company Detail
Table 89. Bio-Techne Corporation Business Overview
Table 90. Bio-Techne Corporation Cell-Based Multiplex Assays Product
Table 91. Bio-Techne Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 92. Bio-Techne Corporation Recent Development
Table 93. Shimadzu Biotech Company Detail
Table 94. Shimadzu Biotech Business Overview
Table 95. Shimadzu Biotech Cell-Based Multiplex Assays Product
Table 96. Shimadzu Biotech Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 97. Shimadzu Biotech Recent Development
Table 98. Abcam Company Detail
Table 99. Abcam Business Overview
Table 100. Abcam Cell-Based Multiplex Assays Product
Table 101. Abcam Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 102. Abcam Recent Development
Table 103. Merck Company Detail
Table 104. Merck Business Overview
Table 105. Merck Cell-Based Multiplex Assays Product
Table 106. Merck Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 107. Merck Recent Development
Table 108. Meso Scale Diagnostics Company Detail
Table 109. Meso Scale Diagnostics Business Overview
Table 110. Meso Scale Diagnostics Cell-Based Multiplex Assays Product
Table 111. Meso Scale Diagnostics Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 112. Meso Scale Diagnostics Recent Development
Table 113. Promega Corporation Company Detail
Table 114. Promega Corporation Business Overview
Table 115. Promega Corporation Cell-Based Multiplex Assays Product
Table 116. Promega Corporation Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 117. Promega Corporation Recent Development
Table 118. Siemens Healthineers Company Detail
Table 119. Siemens Healthineers Business Overview
Table 120. Siemens Healthineers Cell-Based Multiplex Assays Product
Table 121. Siemens Healthineers Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 122. Siemens Healthineers Recent Development
Table 123. Boster Biological Technology Company Detail
Table 124. Boster Biological Technology Business Overview
Table 125. Boster Biological Technology Cell-Based Multiplex Assays Product
Table 126. Boster Biological Technology Revenue in Cell-Based Multiplex Assays Business (2018-2023) & (US$ Million)
Table 127. Boster Biological Technology Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Based Multiplex Assays Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell-Based Multiplex Assays Market Share by Type: 2022 VS 2029
Figure 3. Flow Cytometry Features
Figure 4. Fluorescence Detection Features
Figure 5. Multiplex Real-Time PCR Features
Figure 6. Others Features
Figure 7. Global Cell-Based Multiplex Assays Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cell-Based Multiplex Assays Market Share by Application: 2022 VS 2029
Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
Figure 10. Hospitals & Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Cell-Based Multiplex Assays Report Years Considered
Figure 13. Global Cell-Based Multiplex Assays Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cell-Based Multiplex Assays Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cell-Based Multiplex Assays Market Share by Region: 2022 VS 2029
Figure 16. Global Cell-Based Multiplex Assays Market Share by Players in 2022
Figure 17. Global Top Cell-Based Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Based Multiplex Assays as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell-Based Multiplex Assays Revenue in 2022
Figure 19. North America Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cell-Based Multiplex Assays Market Share by Country (2018-2029)
Figure 21. United States Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cell-Based Multiplex Assays Market Share by Country (2018-2029)
Figure 25. Germany Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cell-Based Multiplex Assays Market Share by Region (2018-2029)
Figure 33. China Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cell-Based Multiplex Assays Market Share by Country (2018-2029)
Figure 41. Mexico Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cell-Based Multiplex Assays Market Share by Country (2018-2029)
Figure 45. Turkey Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cell-Based Multiplex Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 48. R&D Systems Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 50. Protavio Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 51. Illumina Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 52. BD Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 53. Luminex Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 54. Agilent Technologies Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 55. Bio-Techne Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 56. Shimadzu Biotech Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 57. Abcam Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 58. Merck Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 59. Meso Scale Diagnostics Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 60. Promega Corporation Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 61. Siemens Healthineers Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 62. Boster Biological Technology Revenue Growth Rate in Cell-Based Multiplex Assays Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 体細胞由来マルチプレックス・アッセイのグローバル市場展望 2023年-2029年：フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他
  • 細胞光学検出装置のグローバル市場展望 2023年-2029年：細胞顕微鏡、フローサイトメトリー、細胞イメージャー
  • がん最小残存病変検査のグローバル市場展望 2023年-2029年：フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、その他
  • 最小残存病変（MRD）検査のグローバル市場展望 2023年-2029年：フローサイトメトリー、ポリメラーゼ連鎖反応、次世代シーケンシング、リキッドバイオプシー
  • Luminexマルチプレックスアッセイのグローバル市場展望 2023年-2029年：タンパク質マルチプレックスアッセイ、核酸マルチプレックスアッセイ、細胞ベースマルチプレックスアッセイ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7440 )"細胞ベースマルチプレックスアッセイの世界市場2023年：フローサイトメトリー、蛍光検出、マルチプレックスリアルタイムPCR、その他" (英文：Global Cell-Based Multiplex Assays Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。